Copyright Reports & Markets. All rights reserved.

Global Drug-Loadable Embolic Microspheres Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Drug-Loadable Embolic Microspheres Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Drug-eluting Microspheres
    • 1.3.3 Radioactive Microspheres
  • 1.4 Market Analysis by Size
    • 1.4.1 Overview: Global Drug-Loadable Embolic Microspheres Consumption Value by Size: 2021 Versus 2025 Versus 2032
    • 1.4.2 1G (<100μm)
    • 1.4.3 2 G (≥100μm)
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Drug-Loadable Embolic Microspheres Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 Primary Liver Cancer
    • 1.5.3 Colorectal Cancer Liver Metastasis
    • 1.5.4 Others
  • 1.6 Global Drug-Loadable Embolic Microspheres Market Size & Forecast
    • 1.6.1 Global Drug-Loadable Embolic Microspheres Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Drug-Loadable Embolic Microspheres Sales Quantity (2021-2032)
    • 1.6.3 Global Drug-Loadable Embolic Microspheres Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Boston Scientific
    • 2.1.1 Boston Scientific Details
    • 2.1.2 Boston Scientific Major Business
    • 2.1.3 Boston Scientific Drug-Loadable Embolic Microspheres Product and Services
    • 2.1.4 Boston Scientific Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boston Scientific Recent Developments/Updates
  • 2.2 Terumo
    • 2.2.1 Terumo Details
    • 2.2.2 Terumo Major Business
    • 2.2.3 Terumo Drug-Loadable Embolic Microspheres Product and Services
    • 2.2.4 Terumo Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Terumo Recent Developments/Updates
  • 2.3 Merit Medical
    • 2.3.1 Merit Medical Details
    • 2.3.2 Merit Medical Major Business
    • 2.3.3 Merit Medical Drug-Loadable Embolic Microspheres Product and Services
    • 2.3.4 Merit Medical Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Merit Medical Recent Developments/Updates
  • 2.4 Varian
    • 2.4.1 Varian Details
    • 2.4.2 Varian Major Business
    • 2.4.3 Varian Drug-Loadable Embolic Microspheres Product and Services
    • 2.4.4 Varian Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Varian Recent Developments/Updates
  • 2.5 Sirtex Medical
    • 2.5.1 Sirtex Medical Details
    • 2.5.2 Sirtex Medical Major Business
    • 2.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Product and Services
    • 2.5.4 Sirtex Medical Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sirtex Medical Recent Developments/Updates
  • 2.6 Suzhou Hengrui Medical Equipment
    • 2.6.1 Suzhou Hengrui Medical Equipment Details
    • 2.6.2 Suzhou Hengrui Medical Equipment Major Business
    • 2.6.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product and Services
    • 2.6.4 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Suzhou Hengrui Medical Equipment Recent Developments/Updates
  • 2.7 ABK Biomedical
    • 2.7.1 ABK Biomedical Details
    • 2.7.2 ABK Biomedical Major Business
    • 2.7.3 ABK Biomedical Drug-Loadable Embolic Microspheres Product and Services
    • 2.7.4 ABK Biomedical Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ABK Biomedical Recent Developments/Updates
  • 2.8 Mermaid Medical
    • 2.8.1 Mermaid Medical Details
    • 2.8.2 Mermaid Medical Major Business
    • 2.8.3 Mermaid Medical Drug-Loadable Embolic Microspheres Product and Services
    • 2.8.4 Mermaid Medical Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mermaid Medical Recent Developments/Updates
  • 2.9 Cardiolink Science
    • 2.9.1 Cardiolink Science Details
    • 2.9.2 Cardiolink Science Major Business
    • 2.9.3 Cardiolink Science Drug-Loadable Embolic Microspheres Product and Services
    • 2.9.4 Cardiolink Science Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cardiolink Science Recent Developments/Updates
  • 2.10 Suzhou Haowei Medical Technology
    • 2.10.1 Suzhou Haowei Medical Technology Details
    • 2.10.2 Suzhou Haowei Medical Technology Major Business
    • 2.10.3 Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Product and Services
    • 2.10.4 Suzhou Haowei Medical Technology Drug-Loadable Embolic Microspheres Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Suzhou Haowei Medical Technology Recent Developments/Updates

3 Competitive Environment: Drug-Loadable Embolic Microspheres by Manufacturer

  • 3.1 Global Drug-Loadable Embolic Microspheres Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturer (2021-2026)
  • 3.3 Global Drug-Loadable Embolic Microspheres Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Drug-Loadable Embolic Microspheres by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Drug-Loadable Embolic Microspheres Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Drug-Loadable Embolic Microspheres Manufacturer Market Share in 2025
  • 3.5 Drug-Loadable Embolic Microspheres Market: Overall Company Footprint Analysis
    • 3.5.1 Drug-Loadable Embolic Microspheres Market: Region Footprint
    • 3.5.2 Drug-Loadable Embolic Microspheres Market: Company Product Type Footprint
    • 3.5.3 Drug-Loadable Embolic Microspheres Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Drug-Loadable Embolic Microspheres Market Size by Region
    • 4.1.1 Global Drug-Loadable Embolic Microspheres Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Drug-Loadable Embolic Microspheres Consumption Value by Region (2021-2032)
    • 4.1.3 Global Drug-Loadable Embolic Microspheres Average Price by Region (2021-2032)
  • 4.2 North America Drug-Loadable Embolic Microspheres Consumption Value (2021-2032)
  • 4.3 Europe Drug-Loadable Embolic Microspheres Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Drug-Loadable Embolic Microspheres Consumption Value (2021-2032)
  • 4.5 South America Drug-Loadable Embolic Microspheres Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Drug-Loadable Embolic Microspheres Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Drug-Loadable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 5.2 Global Drug-Loadable Embolic Microspheres Consumption Value by Type (2021-2032)
  • 5.3 Global Drug-Loadable Embolic Microspheres Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Drug-Loadable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 6.2 Global Drug-Loadable Embolic Microspheres Consumption Value by Application (2021-2032)
  • 6.3 Global Drug-Loadable Embolic Microspheres Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Drug-Loadable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 7.2 North America Drug-Loadable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 7.3 North America Drug-Loadable Embolic Microspheres Market Size by Country
    • 7.3.1 North America Drug-Loadable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Drug-Loadable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Drug-Loadable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 8.2 Europe Drug-Loadable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 8.3 Europe Drug-Loadable Embolic Microspheres Market Size by Country
    • 8.3.1 Europe Drug-Loadable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Drug-Loadable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Drug-Loadable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Drug-Loadable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Drug-Loadable Embolic Microspheres Market Size by Region
    • 9.3.1 Asia-Pacific Drug-Loadable Embolic Microspheres Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Drug-Loadable Embolic Microspheres Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Drug-Loadable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 10.2 South America Drug-Loadable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 10.3 South America Drug-Loadable Embolic Microspheres Market Size by Country
    • 10.3.1 South America Drug-Loadable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Drug-Loadable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Drug-Loadable Embolic Microspheres Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Drug-Loadable Embolic Microspheres Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Drug-Loadable Embolic Microspheres Market Size by Country
    • 11.3.1 Middle East & Africa Drug-Loadable Embolic Microspheres Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Drug-Loadable Embolic Microspheres Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Drug-Loadable Embolic Microspheres Market Drivers
  • 12.2 Drug-Loadable Embolic Microspheres Market Restraints
  • 12.3 Drug-Loadable Embolic Microspheres Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Drug-Loadable Embolic Microspheres and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Drug-Loadable Embolic Microspheres
  • 13.3 Drug-Loadable Embolic Microspheres Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Drug-Loadable Embolic Microspheres Typical Distributors
  • 14.3 Drug-Loadable Embolic Microspheres Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Drug-Loadable Embolic Microspheres market size was valued at US$ 1524 million in 2025 and is forecast to a readjusted size of US$ 2680 million by 2032 with a CAGR of 8.5% during review period.
    Drug-loadable embolic microsphere is a therapeutic embolic agent used to block tumor blood flow and drug delivery. Loadable embolic microspheres delivered by transarterial chemoembolization (TACE) serve as a therapeutic embolic to stop blood flow to tumors and a drug delivery vehicle.
    In 2024, global Drug-loadable embolic microsphere production reached approximately 1067 L, with an average global market price of around US$1300 per mL. The single-line production capacity for drug-loadable embolic microspheres is approximately 20-100 liters/year. The industry's gross profit margin is approximately 60% to 80%. Raw materials (polymers such as PVA and drugs) account for the largest portion of the cost structure, approximately 30% to 40%, with the remainder comprising production consumables and packaging materials, labor costs, and manufacturing expenses. Upstream raw material suppliers provide key raw materials such as biodegradable polymers and drug-loaded materials; downstream players primarily include hospitals and medical institutions (as end users, performing TACE treatments) and dealers and distributors (responsible for regional product sales and promotion).
    The drug-loadable embolic microsphere segment is maturing from a niche adjunct to a core interventional oncology platform that couples mechanical occlusion with localized pharmacotherapy. Advances in polymer science and controlled-release formulation have improved particle uniformity and intratumoral drug delivery predictability, which enhances procedural reproducibility and clinician confidence. Broad clinical adoption depends less on incremental device features than on robust clinical evidence and regulatory clarity; products backed by multicenter studies and clear procedural protocols are more likely to be integrated into standard care pathways. Manufacturing reliability—consistent batch-to-batch performance, scalable production, and stringent quality systems—is a critical commercial differentiator, since clinicians and hospitals prioritize devices with dependable supply and consistent behavior. Cost and accessibility remain meaningful constraints in lower-resource settings, preserving a role for simpler embolics even as high-value drug-eluting platforms gain ground in advanced centers. Strategically, winners will be those combining differentiated drug-delivery chemistry, demonstrable clinical benefit, and pragmatic manufacturing scale-up, enabling integration with image-guided workflows and personalized therapeutic strategies.
    This report is a detailed and comprehensive analysis for global Drug-Loadable Embolic Microspheres market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Drug-Loadable Embolic Microspheres market size and forecasts, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2021-2032
    Global Drug-Loadable Embolic Microspheres market size and forecasts by region and country, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2021-2032
    Global Drug-Loadable Embolic Microspheres market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (L), and average selling prices (US$/mL), 2021-2032
    Global Drug-Loadable Embolic Microspheres market shares of main players, shipments in revenue ($ Million), sales quantity (L), and ASP (US$/mL), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Drug-Loadable Embolic Microspheres
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Drug-Loadable Embolic Microspheres market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific, Terumo, Merit Medical, Varian, Sirtex Medical, Suzhou Hengrui Medical Equipment, ABK Biomedical, Mermaid Medical, Cardiolink Science, Suzhou Haowei Medical Technology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Drug-Loadable Embolic Microspheres market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Drug-eluting Microspheres
    Radioactive Microspheres
    Market segment by Size
    1G (<100μm)
    2 G (≥100μm)
    Market segment by Application
    Primary Liver Cancer
    Colorectal Cancer Liver Metastasis
    Others
    Major players covered
    Boston Scientific
    Terumo
    Merit Medical
    Varian
    Sirtex Medical
    Suzhou Hengrui Medical Equipment
    ABK Biomedical
    Mermaid Medical
    Cardiolink Science
    Suzhou Haowei Medical Technology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Drug-Loadable Embolic Microspheres product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Drug-Loadable Embolic Microspheres, with price, sales quantity, revenue, and global market share of Drug-Loadable Embolic Microspheres from 2021 to 2026.
    Chapter 3, the Drug-Loadable Embolic Microspheres competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Drug-Loadable Embolic Microspheres breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Drug-Loadable Embolic Microspheres market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Drug-Loadable Embolic Microspheres.
    Chapter 14 and 15, to describe Drug-Loadable Embolic Microspheres sales channel, distributors, customers, research findings and conclusion.

    Buy now